Verruguin Liquid Wart Remover

Manufacturer
Germa Products, LLC
Effective date
2026-10-09
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
daily-update
Hydrated at
2026-10-13 04:03:25

Label at a glance#

ProductVerruguin Liquid Wart Remover
Active ingredientSALICYLIC ACID
Label structure10 sections

Indications and uses

for the removal of common warts. The common wart is easily recognized by the rough “cauliflower-like” appearance of the surface.

Dosage and administration

• Wash affected area and dry thoroughly. • Apply one drop at a time with applicator to sufficiently cover each wart. • Let dry. • Repeat this procedure once or twice daily as needed for up to 2 weeks.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 17%

Uses

OTC - WHEN USING SECTION

for the removal of common warts. The common wart is easily recognized by the rough “cauliflower-like” appearance of the surface.

INDICATIONS & USAGE SECTION

for the removal of common warts. The common wart is easily recognized by the rough “cauliflower-like” appearance of the surface.

Purpose

OTC - PURPOSE SECTION

Wart Remover Liquid

Warnings

WARNINGS SECTION

For external use only. Flammable: Keep away from fire or flame.
Do not use: in or near eyes or mucous membranes. On irritated skin. If prone to allergic reaction to any ingredient in this product. On moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. On any area that is infected or reddened. If you are a diabetic, or have poor blood circulation n on large area of the body, on wounds or damaged skin.
When using this product: If product gets in eyes, flush with water for 15 minutes. Do not inhale vapors. Cap bottle tightly and store at room temperature away from heat.
If discomfort persists, see your doctor.
Stop use and ask a doctor if; Irritation occurs n condition worsens or does not improve or discomfort persists. If pregnant or breast-feeding. Ask a health professional before use. Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Warnings

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

• Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Other Information

OTHER SAFETY INFORMATION

Store between 20º to 25ºC (68º to 77ºF). Cap bottle tightly. Use product in well ventilated area. Avoid inhaling vapors. Retain packaging for full labeling.

Directions

DOSAGE & ADMINISTRATION SECTION

• Wash affected area and dry thoroughly.

• Apply one drop at a time with applicator to sufficiently cover each wart.

• Let dry.

• Repeat this procedure once or twice daily as needed for up to 2 weeks.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Flexible Collodion (Alcohol, Camphor, Mineral Oil), and Isopropyl Alcohol.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Verruguin BoxVerruguin Box

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73635-581073635-5810-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72025-10-10full-release2026-06-01 01:38:39
62024-10-15full-release2026-06-01 00:25:51

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
40d09f37-2115-1167-e063-6294a90abc32bf7842a2-9c07-3fc3-e053-2995a90a36c12025-10-10WarningsExact identifier
spl set id: bf7842a2-9c07-3fc3-e053-2995a90a36c1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.